DE69933033D1 - Myotilin, ein actin-organisierendes protein - Google Patents

Myotilin, ein actin-organisierendes protein

Info

Publication number
DE69933033D1
DE69933033D1 DE69933033T DE69933033T DE69933033D1 DE 69933033 D1 DE69933033 D1 DE 69933033D1 DE 69933033 T DE69933033 T DE 69933033T DE 69933033 T DE69933033 T DE 69933033T DE 69933033 D1 DE69933033 D1 DE 69933033D1
Authority
DE
Germany
Prior art keywords
actin
myotilin
actinin
alpha
myotiline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69933033T
Other languages
English (en)
Other versions
DE69933033T2 (de
Inventor
Olli Carpen
Paula Salmikangas
Mikaela Groenholm
Leena Heiska
Olli-Matti Mykkaenen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Licentia Oy
Original Assignee
Licentia Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Licentia Oy filed Critical Licentia Oy
Publication of DE69933033D1 publication Critical patent/DE69933033D1/de
Application granted granted Critical
Publication of DE69933033T2 publication Critical patent/DE69933033T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4707—Muscular dystrophy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69933033T 1998-07-17 1999-07-14 Myotilin, ein actin-organisierendes protein Expired - Fee Related DE69933033T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9316998P 1998-07-17 1998-07-17
US93169P 1998-07-17
PCT/FI1999/000625 WO2000004145A2 (en) 1998-07-17 1999-07-14 Myotilin, an actin-organizing protein

Publications (2)

Publication Number Publication Date
DE69933033D1 true DE69933033D1 (de) 2006-10-12
DE69933033T2 DE69933033T2 (de) 2007-04-05

Family

ID=22237546

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69933033T Expired - Fee Related DE69933033T2 (de) 1998-07-17 1999-07-14 Myotilin, ein actin-organisierendes protein

Country Status (7)

Country Link
US (1) US6458929B1 (de)
EP (1) EP1098971B1 (de)
AT (1) ATE338119T1 (de)
AU (1) AU756370B2 (de)
CA (1) CA2333469C (de)
DE (1) DE69933033T2 (de)
WO (1) WO2000004145A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ656500A0 (en) * 2000-03-28 2000-04-20 Autogen Pty Ltd A method of treatment and agents for same
US10196636B2 (en) 2011-04-21 2019-02-05 Nationwide Children's Hospital, Inc. Recombinant virus products and methods for inhibition of expression of myotilin
EP2699673B1 (de) * 2011-04-21 2018-09-19 Nationwide Children's Hospital, Inc. Rekombinante virusprodukte und verfahren zur expressionshemmung von myotilin
ES2830256T3 (es) * 2015-09-14 2021-06-03 Nationwide Childrens Hospital Inc Productos de virus recombinante y procedimientos de inhibición de expresión de miotilina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672694A (en) * 1995-10-24 1997-09-30 University Of Iowa Research Foundation β-sarcoglycan nucleic acid sequence, and nucleic acid probes
US5837680A (en) * 1996-02-16 1998-11-17 Children's Medical Center Corporation Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis

Also Published As

Publication number Publication date
EP1098971B1 (de) 2006-08-30
EP1098971A2 (de) 2001-05-16
US6458929B1 (en) 2002-10-01
DE69933033T2 (de) 2007-04-05
AU5043599A (en) 2000-02-07
CA2333469C (en) 2007-11-13
WO2000004145A3 (en) 2000-04-20
CA2333469A1 (en) 2000-01-27
AU756370B2 (en) 2003-01-09
ATE338119T1 (de) 2006-09-15
WO2000004145A2 (en) 2000-01-27

Similar Documents

Publication Publication Date Title
Wang Substrate deformation determines actin cytoskeleton reorganization: a mathematical modeling and experimental study
DE69634640D1 (de) Mutierte alpha-amylase enzyme mit erhöhter stabilität
ES2121479T3 (es) Solucion estabilizadora para proteinas y peptidos.
BR9708209A (pt) Polipeptídeo isolado tendo atividade fitase sequência de ácido nucleico isolada construção de ácido nucleico vetor de expressão recombinante célula hospedeira recombinante processo para produzir o polipeptídeo composição de alimento ou ração processo para reduzir os níveis de fitato em estrume de animais processo para liquefazer um amido e uso de um polipeptídeo
BR9709418A (pt) Aperfeiçoamento em composições contendo creatina ou em relação ás mesmas
Skripnikova et al. Interaction of smooth muscle caldesmon with S‐100 protein
DE69132275D1 (de) Beta-type ähnlicher transformierender wachstumfaktor
ATE397655T1 (de) Verfahren zur erhöhung der leistungsfähigkeit der rekombinanten aav produktion
DE69933033D1 (de) Myotilin, ein actin-organisierendes protein
DE69631972D1 (de) Proliferationsinhibitor von endothellzellen und dessen verwendung
Franke et al. Plakoglobin is a component of the filamentous subplasmalemmal coat of lens cells
FR2827174B1 (fr) Utilisation de peptides pour augmenter l'adhesion cellulaire
BR9917475A (pt) Processo para a manufatura de compostos, modificação do processo, e, biblioteca de inúmeros compostos
AU2149099A (en) Pseudo-type retroviral vectors with modifiable surface capsid proteins
DE68917837D1 (de) Peptid-Verbindungen.
ATE227995T1 (de) Verwendung von pseudopterosin zur förderung der wundheilung
WO1999061589A3 (en) Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
HUP9900750A2 (hu) Gén kifejezésére szolgáló promóterek
ES2144626T3 (es) Uso de peptidos de adhesion celular para la modificacion del poder de adhesion de celulas eucarioticas entre si.
TR200000140T2 (tr) Endojenik gen etkinliği ile insan proteini üretimi için insan hücre sıralarının belirlenmesi
Higuti Conformational coupling in H+-pumps and ATP synthesis—its analysis with anisotropic inhibitors of energy transduction in oxidative phosphorylation
CA2146240A1 (en) Increased production of secreted proteins by recombinant eukaryotic cells
FI972909A0 (fi) Oekad produktion av avsoendrade proteiner genom rekombinatjaestceller
AR024430A1 (es) Proteinas insecticidas y combinaciones sinergicas de las mismas
Fu et al. Ameliorated stress related proteins are associated with improved cardiac function by sarcoplasmic reticulum calcium ATPase gene transfer in heart failure

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee